Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current ...

Management raised the quarterly dividend 6% to $2.38 per share, resulting in an attractive 3.5% yield at the current stock price. The balance sheet remains rock-solid even after the $27.8 billion ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Piper Sandler’s price target suggests a potential upside ... Institutional investors own 76.50% of the company’s stock. Amgen Inc discovers, develops, manufactures, and delivers human ...

Access Amgen stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Amgen reported strong Q1 results with a 9% YoY ... as traders appeared to go for more risk-on slices of the stock market. Guidance was reaffirmed, but it was a touch light, though it was a robust ...

Amgen has gotten caught up in the broader market decline, but its business is unscathed. Its obesity drug sales are about to boom, making the stock look like a buy.